• Strategy
  • Portfolio
  • People
  • Careers
  • News
  • Blog
  • Contact Us
Foresite News
Press Releases
Portfolio News

For press inquiries click here to contact us.

Triangle Business Journal

Sage Therapeutics targets Triangle for national postpartum depression support center

August 13, 2018
Forbes

RegenXBio Gene Therapy Shows Early Promise For Eye Disease; Cholesterol Treatment Results Mixed

August 8, 2018
GenomeWeb

Natera Q2 Revenues Climb 21 Percent

August 1, 2018
FierceBiotech

Epizyme nabs SQZ Biotech, Tesaro biotech veteran Shefali Agarwal as CMO

July 28, 2018
GenomeWeb

NanoString Nets $47M in Public Stock Offering

July 23, 2018
FiercePharma

Sweating it out? Dermira’s armpit awareness push gets Qbrexza ready to roll

July 9, 2018
Business Insider

Startups are pioneering a dramatic shift in how we spot and treat depression — and you can try some of their new tools right now

July 9, 2018
Drug Delivery

Sage Therapeutics’ chief scientist on discovering drugs and taking risks

June 29, 2018
CNBC

With food allergies on the rise, biotech Aimmune is focusing on raising patients’ tolerance

June 28, 2018
FierceBiotech

Arcus, Infinity team up on triple-combination studies in TNBC and ovarian cancer

June 26, 2018
Page 15 of 26« First«...10...1314151617...20...»Last »

Please see important disclaimers in the Terms section.


©2022 Foresite Capital Management, LLC. Site by GOODLAB

    • Strategy
    • Portfolio
    • People
    • Careers
    • News
    • Blog
    • Contact Us
    • Contact Us
    • Foresite Labs
    • Investor Login
    • Terms
    • Privacy Policy
    Close
    • News
    • Blog
    • Foresite Labs
    • Contact Us
    • Home
    • Strategy
    • Portfolio
    • People
    • Careers
    • News
    • Blog
    • Contact Us
    • Foresite Labs
    • Investor Login
    • Terms
    • Privacy Policy
      • Blog
      • Careers
      • Contact Us
      • Disclosures
      • Home
      • Legal Disclaimers
      • Pardes Biosciences Legend
      • Privacy Policy
      • Strategy
      • Terms

    ©2025 Foresite Capital Management, LLC.

    Site by Goodlab

    Close